Caspase-4: A Therapeutic Target for Peptic Ulcer Disease

  • Zaslona Z
  • Flis E
  • Nulty C
  • et al.
10Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Peptic ulcers are caused by the interaction between bacterial and host factors. This study demonstrates enhanced expression of caspase-4 in peptic ulcer patient biopsies, indicating that pyroptosis and noncanonical inflammasome activity may be processes involved in peptic ulcer disease. We show that primary murine macrophages infected with Helicobacter pylori upregulate caspase-11 (the ortholog of human caspase-4), activate caspase-1, and secrete IL-1β. We demonstrate that misoprostol (a stable PGE1 analogue) decreased IL-1β secretion and delayed lethality in vivo in a murine peritonitis model. PGE2 was shown to inhibit caspase-11–driven pyroptosis and IL-1β secretion in macrophages. Overall, we provide evidence for a pathological role of caspase-4/11 in peptic ulcer disease and propose that targeting caspase-4 or inhibiting pyroptosis may have therapeutic potential in the management of peptic ulcers.

Cite

CITATION STYLE

APA

Zaslona, Z., Flis, E., Nulty, C., Kearney, J., Fitzgerald, R., Douglas, A. R., … Creagh, E. M. (2020). Caspase-4: A Therapeutic Target for Peptic Ulcer Disease. ImmunoHorizons, 4(10), 627–633. https://doi.org/10.4049/immunohorizons.2000080

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free